Stay informed Sign up for our newsletter and be the first to know.
Stay informed Sign up for our newsletter and be the first to know.
Brilliant Investment Thinking by Advisers for Advisers.
ASX
-0.70%
S&P
-2.64%
AUD
$0.71

The world after COVID-19

As the year from hell winds down around the world, an influx of 2021 outlooks have flooded adviser inboxes around Australia. Most should be taken with a grain of salt,...
Read More

The recession is over, where to now?

There are positive signs for the Australian economy following Wednesday's third quarter GDP figure. It was a positive reading of 3.3% quarter on quarter, signalling a rebound in the economy...
Read More

Seek (ASX:SEK) under short attack

Sentiment shifts US market rallies, JB Hi-Fi (ASX:JBH) sold off, Seek (ASX:SEK) under short attack It's looking like a tough end to October after what has been a very strong...
Read More

Inflation returns, Coles (ASX:COL) sales boom

Inflation returns, Coles (ASX:COL) sales boom, US staggers down 3%, ASX to open over 1% lower The ASX 200 (ASX:XJO) staged a solid comeback after a weak opening, finishing 0.1% higher.  The strength came...
Read More

RBA: Recession is over, ASX 200 slumps 1.7%

RBA: Recession is over, ASX200 slumps 1.7%, stronger open ahead The ASX 200 (ASX:XJO) finished off the day's lows falling 1.7% on Tuesday after a weak global lead.  The good...
Read More

Another negative week for the ASX

Another negative week for the ASX, Trump-Biden debate, Link (ASX:LNK) undervalued The ASX 200 (ASX:XJO) finished 0.1% lower on Friday keeping the index in negative territory for the week, down 0.2%.  The...
Read More

ASX pares losses, Healius (ASX:HLS) delivers

Volatility continues, ASX pares losses, Healius (ASX:HLS) delivers, AMP (ASX:AMP) sold off, positive morning ahead The ASX 200 (ASX:XJO) pared early losses to finish down just 0.3% on Wednesday, with oil...
Read More

Getting to know Angela Ashton

This week we spoke with Angela Ashton, founder of Evergreen Consulting, who recently launched her Investment Research business. Angela, can you tell us a little about yourself; what has been...
Read More

ASX update; COVID-19 impacting Macquarie Group

Vaccine trial restart boosts markets, ASX strength to continue, COVID-19 impacting Macquarie Group A positive lead from Wall Street and news that AstraZeneca plc (NYSE:AZN) had resumed their vaccine trial...
Read More